Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403727 · ClinicalTrials.gov registry record
Electromagnetic Tracking of Devices During Biopsy Procedures
A clinical trial of Liver Tumors, sponsored by Philips Healthcare.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01403727 is a study of Liver Tumors that has completed, run by Philips Healthcare. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01403727, a study of Liver Tumors, has completed, sponsored by Philips Healthcare.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the trial is to evaluate the differences between PercuNav assisted and unassisted biopsy in the areas of CT radiation dose, procedure time and biopsy accuracy. This prospective, randomized, controlled trial will compare the use of electromagnetic tracking and image guidance (CT) during biopsy procedures verses the typical CT image guided procedure alone.
Conditions Studied
Study Locations (1)
New York
- Mount Sinai Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01403727
The ClinicalTrials.gov registry entry for NCT01403727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Healthcare, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01403727 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01403727 about?
NCT01403727 is a clinical study titled "Electromagnetic Tracking of Devices During Biopsy Procedures". The purpose of the trial is to evaluate the differences between PercuNav assisted and unassisted biopsy in the areas of CT radiation dose, procedure time and biopsy accuracy. This prospective, randomized, controlled trial will compare the use of electromagnetic tracking and image guidance (CT) duri...
What is the current status of trial NCT01403727?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-11. Estimated completion is 2013-05.
What conditions does trial NCT01403727 study?
This clinical trial studies the following conditions: Liver Tumors.
Who is sponsoring clinical trial NCT01403727?
This trial is sponsored by Philips Healthcare, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01403727 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.